SK Hynix's Grand Realignment: A $40 Billion Pivot That Pits Record Profits Against a Market's Doubts
Published on 08/10/2026 at 18:51 | Redaktion boerse-global.de
The arithmetic of SK Hynix's current moment is almost contradictory. The South Korean memory chip giant just posted what it calls a historic quarter — a net profit of 93.9226 trillion won on revenue of 79.3187 trillion won — and yet its shares have been bleeding for weeks. The disconnect between the company's operational reality and its stock market reception has rarely been starker.
The explanation lies partly in what investors see ahead: a capital expenditure program of 54 trillion won for new fabrication facilities in Yongin and Cheongju, a potential exit from a key Chinese plant, and a high-stakes race to scale HBM4 production before rivals close the gap.
A Record Quarter With a Caveat
The second quarter of 2026 delivered numbers that would typically trigger celebrations. Operating profit reached 60.5426 trillion won, while net income was boosted by valuation gains on investment holdings — Reuters specifically pointed to the company's stake in Kioxia as a supporting factor. First-half cumulative revenue crossed the 100 trillion won threshold for the first time in corporate history.
But the market's reaction was muted at best. Revenue fell short of analyst projections even as profit beat expectations, and Reuters reported that the stock declined after the earnings release. Investors were pricing in two worries: a possible softening in AI-related capital spending and the scale of the company's own investment commitments. The market's skepticism has only deepened since — the shares have lost 9.38 percent in a seven-day stretch.
The China Question
While the market fixates on the earnings print, a potentially more consequential story is unfolding in Chongqing. SK Hynix is exploring the sale of its packaging and testing facility there, with media reports floating a price of around 4 trillion won, or roughly $3 billion. The company told the Korea Exchange on August 10 that nothing has been decided and it is merely reviewing options to strengthen its packaging business — a carefully worded statement that does little to obscure the direction of travel.
Should investors sell immediately? Or is it worth buying SK Hynix?
The strategic logic is clear enough. Roughly 30 to 35 percent of SK Hynix's DRAM capacity and 35 to 40 percent of its NAND capacity sits at Chinese sites. A sale would shrink that footprint further, freeing capital for the HBM4 buildout while reducing exposure to geopolitical friction in the wake of US export controls. But it also carries risks: potential regulatory retaliation from Beijing, and a hit to cost efficiency in the NAND business, which still contributes meaningfully to revenue.
The Bull Case, Such as It Is
Despite the recent carnage — the stock is down roughly 35 percent on a monthly basis and sits 52.46 percent below its 52-week high of 2,987,000 won, reached on June 25 — the longer-term picture retains some resilience. The shares remain up 118.56 percent year-to-date and trade about 17 percent above the 200-day moving average of approximately 1.21 million won. The relative strength index of 39 suggests oversold conditions, though that alone signals nothing about a reversal.
The fundamental wager for optimists is that HBM4 demand could grow by as much as 40 percent in 2027. If that materializes, the massive investments in Yongin and Cheongju — alongside a $3.87 billion facility in Indiana — would pay off faster than the market currently assumes. A China retreat, in this framing, is not a retreat at all but a disciplined reallocation of capital toward the highest-growth segment of the memory market.
The Bear Case, and the Clock
The bears have their own arithmetic. Annualized 30-day volatility stands at nearly 146 percent, a figure that speaks to persistent market anxiety. The stock's distance from its 50-day average exceeds 32 percent, and no stabilization is yet visible. The company has confirmed that HBM4 mass production began in the second quarter of 2026, with output expected to ramp further in the second half — but the question is whether that ramp arrives quickly enough.
Chinese competitor CXMT just completed a $9.8 billion initial public offering, with the stock surging on its first trading day. That war chest gives the challenger precisely the firepower needed to close the technology gap faster than previously anticipated. If SK Hynix's new capacity in South Korea or the US faces delays, the transition period could prove costly in market share terms.
What Happens Next
The near-term calendar offers two potential catalysts. SK Hynix must deliver a follow-up statement to the Korea Exchange within a month regarding the Chongqing situation. And by the end of the third quarter of 2026, the market expects updates on HBM pricing and any potential capital returns to shareholders.
For now, the technical picture hinges on that 200-day average near 1.21 million won. The stock, at roughly 1.42 million won, remains above it — but a rushed or undervalued sale of the China facility could test that floor. The company's strategic direction is increasingly clear: double down on AI memory at home and in the US, retrench from China, and trust that the HBM4 cycle will vindicate the scale of the bet. Whether the market shares that conviction is a question the coming weeks will answer.
Ad
SK Hynix Stock: New Analysis - 10 August
Fresh SK Hynix information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
